US 7759363
Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7759363 (Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists) held by Theravance, Inc. expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14